Homology Medicines, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€41.20M -57.7% N/A -€58.38M -29.5% N/A
    €997.67K -64.0% -€97.49M -23,487.4% -9,771.7% -98 pp -€82.85M -14.6% -8,304.7% -48 pp
    €2.77M -90.6% €416.85K -100.5% 15.1% +3.0 pp -€96.98M +4.7% -3,503.0% -32 pp
    €29.32M +1,157.3% -€82.49M -24.8% -281.4% +44 pp -€92.65M +18.5% -316.0% +30 pp
    €2.33M +62.2% -€109.71M +29.9% -4,704.8% +12 pp -€78.19M +30.3% -3,353.0% +8.2 pp
    €1.44M -54.8% -€84.48M +71.1% -5,875.7% -43 pp -€60.00M +294.5% -4,173.2% -37 pp
    €3.18M +∞% -€49.38M +90.8% -1,553.1% -16 pp -€15.21M -308.9% -478.4% -4.8 pp
    €0.00 +NaN% -€25.88M +272.7% N/A €7.28M -229.9% N/A
    €0.00 -€6.94M N/A -€5.61M N/A

    Notifications